Clinical Trial of Efficacy and Safety of Kolofort in Functional Dyspepsia Patients

Summary

Purpose of the study: To obtain additional data on efficacy and safety of Kolofort in the treatment of patients with functional dyspepsia.

Timeline

Start

2017-06-28

Primary completion

2020-01-11

Completion

2020-01-11

Outcome

Met primary endpoint

registry analysis (superiority test); Kolofort vs Placebo; p = 0.041; Mean Difference (Final Values) 0.94 (95% CI 0.04 to 1.85); ANOVA NCT03119766 ↗

Drugs

Indications